Creso Pharma Limited announced that it has signed a binding Letter of Intent with Ceyoka Health (Pvt) Ltd. to geographically expand the distribution of its innovative therapeutic medicinal cannabis products into Sri Lanka. The partnership will initially focus on gaining the necessary regulatory acceptance for Creso's flag-ship medicinal cannabis product, cannAFFORD® 50, to be sold as a therapeutic product in Sri Lanka via approved channels. The partnership will then look to explore a wide range of other joint initiatives firmly focused on innovative therapeutic and medicinal products containing hemp extracts which can help to improve the lives of patients.